Brenda Melendez

5PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 14, 2025
Microbial signals in primary and metastatic brain tumors.

Golnaz Morad, Ashish V Damania, Brenda Melendez

|Aug 01, 2025
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.

Anne Knisely, Yibo Dai, Graham L Barlow

|Jul 10, 2025
Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine Tumors.

Reed I Ayabe, Y David Seo, Brenda Melendez

|Jun 26, 2024
Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion.

Mikayla B Bowen, Brenda Melendez, Qian Zhang

|Mar 16, 2021
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.

Shubhra Singh, Zhilan Xiao, Karishma Bavisi

Pageof 1

Frequent Collaborators

4 joint publications

Alexander J Lazar

3 joint publications

Jennifer A Wargo

2 joint publications

Manoj Chelvanambi

2 joint publications

Shannon N Westin